X-66027490-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_007268.3(VSIG4):c.794C>T(p.Thr265Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000141 in 1,203,102 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_007268.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112452Hom.: 0 Cov.: 23 AF XY: 0.0000289 AC XY: 1AN XY: 34620
GnomAD3 exomes AF: 0.0000239 AC: 4AN: 167533Hom.: 0 AF XY: 0.0000182 AC XY: 1AN XY: 54927
GnomAD4 exome AF: 0.0000138 AC: 15AN: 1090650Hom.: 0 Cov.: 29 AF XY: 0.00000839 AC XY: 3AN XY: 357402
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112452Hom.: 0 Cov.: 23 AF XY: 0.0000289 AC XY: 1AN XY: 34620
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 20, 2023 | The c.794C>T (p.T265I) alteration is located in exon 5 (coding exon 5) of the VSIG4 gene. This alteration results from a C to T substitution at nucleotide position 794, causing the threonine (T) at amino acid position 265 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at